DODAVIPRONE 125 MG CAPSULE

🧪 Composition

• Active Ingredient: Dordaviprone
• Dosage Form: Oral Capsule
• Strength: 125 mg

✅ Uses

• Used for the treatment of eligible patients with diffuse midline glioma (DMG) harboring the H3 K27M mutation, according to approved indications.
• Helps slow tumor progression in selected patients.
• Supports disease management as part of a personalized oncology treatment plan.
• Intended for use under specialist supervision and based on appropriate diagnostic evaluation.

💉 Dosage

Take Dordaviprone 125 mg exactly as prescribed by your healthcare provider. The dosage and treatment schedule depend on the patient’s age, medical condition, and response to therapy. Swallow the capsules whole with water and follow your physician’s instructions carefully.

⚠️ Precautions

• Use only under the supervision of a qualified healthcare professional.
• Regular clinical assessments and laboratory monitoring may be required during treatment.
• Inform your doctor about any liver disease, kidney disorders, or other medical conditions before starting therapy.
• Report persistent nausea, vomiting, severe fatigue, or any unusual symptoms to your healthcare provider promptly.

📦 Storage

Store the capsules at room temperature in a cool, dry place away from heat, moisture, and direct sunlight. Keep the medicine in its original packaging and out of the reach of children.

⭐ Conclusion

Dordaviprone 125 mg is an emerging targeted therapy for eligible patients with H3 K27M-mutant diffuse midline glioma. When used under specialist supervision, it may help manage disease progression and support improved clinical outcomes. Always follow your healthcare provider’s instructions for safe and effective treatment.